7[3]Roberts W L,Sedrick R,Moulton L,et al.Evaluation of four antomared high-senstivity C-reactive protein methods:implications for clinical and epidem iological applitations[J].Clin Chem,2000,46(4):461-468.
9[5]Erlandsen E J. Renders E.Reference in terval for serum C-reactive protein in healthy blood donors using the Date Behring N Latex CRP mono assay[J].Scand J Clin Lab Invest,2000,60(1):37-43.
10[6]ROhde L E,Hennekens C H,Ridker P M.Survey of C-reactive protin and cardiovascular risk factors in apparently healthy men[J].Am J CardioI,1999,84(9):1018-1022.
8Mudd JO, Borlaug BA, Johnston PV, et al. Beyond low-density lipoprotein cholesterol : defining the role of low-density lipoprotein heterogeneity in coronary artery disease [ J ]. J Am Coll Cardiol, 2007,50 (18) : 1735-1741.
9Arnaud C, Dematteis M, Pepin JL, et al. Obstructive sleep apnea,immuno-inflammation, and atherosclerosis [ J ]. Semin Immunopathol, 2009,31(1) :113-125.
10Shahar E, Whitney CW, Redline S, et al. Sleep-disordered breathing and cardiovascular disease : cross-sectional results of the Sleep Heart Health Study[J]. Am J Respir Crit Care Med,2001,163 ( 1 ) : 19- 25.
